Oxford Properties Acquires Life Science Portfolio in California and Boston for $276M

Global investor, asset manager and developer Oxford Properties has acquired four life science assets totaling 415,000 square feet as well as developable land for $276 million. The assets are located in the San Francisco Bay Area and the Greater Boston area.

In a partnership with San Francisco-based real estate developer City Center Realty Partners (CCRP), Oxford acquired Emeryville Public Market, a 148,000-square-foot mixed-use project with lab, retail, food and office space in the life sciences cluster of Emeryville in the San Francisco Bay Area.

Oxford also acquired three assets in the Greater Boston area. The properties include 33 New York Avenue, a recently completed 114,000 square foot biomanufacturing facility that is 100% leased to Replimune Group Inc and CRISPR Therapeutics as well as 1 & 5 Mountain Road, two adjacent buildings that comprise 153,000 square feet and are currently leased to Sanofi.

Newmark’s Steven Golubchik and Nicholas Bicardo represented the seller of Emeryville Public Market, a a joint venture between Angelo Gordon and CCRP. The seller of the Boston properties was not disclosed.

*Pictured above is Emeryville Public Market in San Francisco

For comments, questions or concerns, please contact David Cohen